참고문헌
- Anderson, S.A., Eisenstat, D.D., Shi, L. and Rubenstein, J.L.: Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science 278:474-476, 1997 https://doi.org/10.1126/science.278.5337.474
- Aubin, J.E. and Bonnelye, E.: Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos. Int. 11:905-913, 2000 https://doi.org/10.1007/s001980070028
- Collin-Osdoby, P., Yu, X., Zheng, H. and Osdoby, P.: RANKL-mediated osteoclast formation from murine RAW264.7 cells. Methods Mol. Med. 80:153-166, 2003
- Ghanem, N., Jarinova, O., Amores, A., Long, Q., Hatch, G., Park, B.K., Rubenstein, J.L.R. and Ekker, M.: Regulatory roles of conserved intergenic domains in vertebrate Dlx bigene clusters. Genome Res. 13:533-543, 2003 https://doi.org/10.1101/gr.716103
- Ghoul-Mazgar, S., Hotton, D., Lezot, F., Blin- Wakkach, C., Asselin, A., Sautier, J.M. and Berdal, A.: Expression pattern of Dlx3 during cell differentiation in mineralized tissues. Bone 37:799-809, 2005 https://doi.org/10.1016/j.bone.2005.03.020
- Hassan, M.Q., Javed, A., Morasso, M.I., Karlin, J., Montecino, M., Wijnen, A.J.V., Stein, G.S., Stein, J.L. and Lian J.B.: Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3 and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. BioI. 24:9248-9261, 2004 https://doi.org/10.1128/MCB.24.20.9248-9261.2004
- Hassan, M.Q., Tare, R.S., Lee, S.H., Mandeville, M., Morasso, M.I., Javed, A., van Wijnen, A.J., Stein, J.L., Stein, G.S. and Lian, J.B.: BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J. BioI. Chem. 281:40515-40526, 2006 https://doi.org/10.1074/jbc.M604508200
- Ishii, M., Iwai, K., Koike, M., Ohshima, S., Kudo-Tanaka, E., Ishii, T., Mima, T., Katada, Y, Miyatake, K., Uchiyama, Y. and Saeki, Y.: RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J. Bone Miner. Res. 21:965-976, 2006 https://doi.org/10.1359/jbmr.060308
- Koide, M., Murase, Y., Yamato, K., Noguchi, T., Okahashi, N. and Nishihara, T.: Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1 alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem. Biophys. Res. Commun. 259:97-102, 1999 https://doi.org/10.1006/bbrc.1999.0715
- Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliot, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W.J.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
- Luchin, A., Suchting, S., Merson, T., Rosol, T.J., Hume, D.A., Cassady, A.I. and Ostrowski, M.C.: Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J. BioI. Chem. 276:36703-36710, 2001 https://doi.org/10.1074/jbc.M106418200
- Marks, S.C. Jr. and Walker, D.G.: The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors. Am. J. Anat. 161:1-10, 1981 https://doi.org/10.1002/aja.1001610102
- Matsuo, K., Galson, D.L., Zhao, C., Peng, L., Laplace, C., Wang, K.Z., Bachler, M.A., Amano, H., Aburatani, H., Ishikawa, H. and Wagner, E.F.: Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. BioI. Chem. 279:26475-26480, 2004 https://doi.org/10.1074/jbc.M313973200
- McGinnis, W. and Krumlauf, R.: Homeobox genes and axial patterning. Cell 68:283-302, 1992 https://doi.org/10.1016/0092-8674(92)90471-N
- Morasso, M.I., Markova, N.G. and Sargent, T.D.: Regulation of epidermal differentiation by a Distal-less homeodomain gene. J. Cell BioI. 135:1879-1887, 1996 https://doi.org/10.1083/jcb.135.6.1879
- Nagai, M. and Sato, N.: Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem. Biophys. Res. Commun. 257:719-723, 1999 https://doi.org/10.1006/bbrc.1999.0524
- Northrop, J.P., Ho, S.N., Chen, L., Thomas, D.J., Timmerman, L.A., Nolan, G.P., Admon, A. and Crabtree, G.R.: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497-502, 1994 https://doi.org/10.1038/369497a0
- Otsuka, E., Notoya, M. and Hagiwara, H.: Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif. Tissue Int. 73:72-77, 2003 https://doi.org/10.1007/s00223-002-1071-0
- Price, J.A., Bowden, D.W., Wright, J.T., Pettenati, M.J. and Hart, T.C.: Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. Hum. Mol. Genet. 7:563-569, 1998a https://doi.org/10.1093/hmg/7.3.563
- Price, J.A., Wright, J.T., Kula, K., Bowden, D.W. and Hart, T.C.: A common DLX3 gene mutation is responsible for tricho-dento-osseous syndrome in Virginia and North Carolina families. J. Med. Genet. 35:825-828, 1998b https://doi.org/10.1136/jmg.35.10.825
- Quinn, J.M.W., Elliott, J., Gillespie, M.T. and Martin, T.J.: A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427, 1998 https://doi.org/10.1210/en.139.10.4424
- Sharma, S.M., Bronisz, A., Hu, R., Patel, K., Mansky, K.C., Sif, S. and Ostrowski, M.C.: MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J. BioI. Chem. 282:15921-15929, 2007 https://doi.org/10.1074/jbc.M609723200
- Simonet, W.S., Lacey, D.L., Dunstanm, C.R., Kelleym, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimomoto, G. and De Rose, M.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:303-319, 1997
- Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T. and Martin, T.J.: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357, 1999 https://doi.org/10.1210/er.20.3.345
- Wright, J.T., Kula, K., Hall, K., Simmons, J.H. and Hart, T.C.: Analysis of the tricho-dento-osseous syndrome genotype and phenotype. Am. J. Med. Genet. 72:197-204, 1997 https://doi.org/10.1002/(SICI)1096-8628(19971017)72:2<197::AID-AJMG14>3.0.CO;2-I
- Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95:3597-3602, 1998a
- Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S., Yano, K., Fujise, N., Sato, Y, Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T. and Higashio, K.: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337, 1998b https://doi.org/10.1210/en.139.3.1329